Regulatory T cells (Tregs) and their therapeutic potential against autoimmune disorders – Advances and challenges
Autoimmune diseases are caused when immune cells act against self-protein. This biological self–non-self-discrimination phenomenon is controlled by a distinct group of lymphocytes known as regulatory T cells (Tregs), which are key inflammatory response regulators and play a pivotal role in immune to...
Main Authors: | Tapas Kumar Goswami, Mithilesh Singh, Manish Dhawan, Saikat Mitra, Talha Bin Emran, Ali A. Rabaan, Abbas Al Mutair, Zainab Al Alawi, Saad Alhumaid, Kuldeep Dhama |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2022-01-01
|
Series: | Human Vaccines & Immunotherapeutics |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/21645515.2022.2035117 |
Similar Items
-
BATF is Required for Treg Homeostasis and Stability to Prevent Autoimmune Pathology
by: Achia Khatun, et al.
Published: (2023-10-01) -
FOXP3+ Treg cells and its gender bias in autoimmune diseases
by: Jia eNie, et al.
Published: (2015-09-01) -
Treg Enhancing Therapies to Treat Autoimmune Diseases
by: Peter J. Eggenhuizen, et al.
Published: (2020-09-01) -
Opportunities for Treg cell therapy for the treatment of human disease
by: Jeffrey A. Bluestone, et al.
Published: (2023-04-01) -
Regulation of CD8+ T cell responses to retinal antigen by local FoxP3+ regulatory T cells
by: Scott W McPherson, et al.
Published: (2012-06-01)